Engineering α-fetoprotein-based gene vaccines to prevent and treat hepatocellular carcinoma: review and future prospects.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4151252)

Published in Immunotherapy on January 01, 2014


Yukai He1, Yuan Hong, Gerald J Mizejewski

Author Affiliations

1: Georgia Regents University Cancer Center, Cancer Immunology, Inflammation & Tolerance Program, Augusta, GA 30907, USA.

Associated clinical trials:

Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma | NCT00669136

Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer | NCT00093548

Articles cited by this

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med (2011) 18.99

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med (2013) 10.63

Positive and negative selection of T cells. Annu Rev Immunol (2002) 8.32

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology (2004) 5.83

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J Exp Med (1998) 5.24

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet (2000) 4.60

Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst (2009) 3.19

Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci (2006) 2.94

Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol (2013) 2.89

Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst (2000) 2.23

Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex. Immunity (2000) 2.13

Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J Immunol (1996) 2.11

Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity (2006) 1.95

Heteroclitic immunization induces tumor immunity. J Exp Med (1998) 1.92

Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. Expert Opin Biol Ther (2012) 1.91

At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy. J Leukoc Biol (2013) 1.90

Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival. Clin Cancer Res (2012) 1.84

Treating cancer with genetically engineered T cells. Trends Biotechnol (2011) 1.83

Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma. Hepatology (2014) 1.76

Introduction to chronic hepatitis B infection. Am J Gastroenterol (2006) 1.69

Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. Cancer Res (1997) 1.67

Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma. Clin Cancer Res (2006) 1.64

Optimization of a self antigen for presentation of multiple epitopes in cancer immunity. J Clin Invest (2006) 1.59

Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen. Proc Natl Acad Sci U S A (2008) 1.59

In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses. J Clin Invest (2003) 1.54

A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides. Clin Cancer Res (2006) 1.48

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma. Hepatology (2009) 1.46

A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma. Dig Liver Dis (2008) 1.32

Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice. Clin Cancer Res (2004) 1.32

A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery. World J Surg (2011) 1.29

T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein. J Immunol (2001) 1.28

Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma. Cancer Res (1999) 1.28

First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinoma. Clin Cancer Res (2013) 1.27

Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein. Cancer Res (1999) 1.26

Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100. Cancer Res (2009) 1.26

T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer. Clin Cancer Res (2003) 1.24

Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial. J Immunother (2005) 1.19

Cytokine-induced killer cells promote antitumor immunity. J Transl Med (2013) 1.16

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma. BMC Cancer (2010) 1.15

Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides. Clin Cancer Res (2012) 1.15

Blockade of programmed death-1 pathway rescues the effector function of tumor-infiltrating T cells and enhances the antitumor efficacy of lentivector immunization. J Immunol (2010) 1.15

Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities. Oncoimmunology (2012) 1.08

The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients. Ann Surg Oncol (2013) 1.07

alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination. Cancer Res (2001) 1.07

Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma. Int J Oncol (2012) 1.04

Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice. Gastroenterology (2000) 1.03

Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma. World J Gastroenterol (2013) 1.02

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review. Int J Clin Pract (2012) 1.00

Lentivector immunization stimulates potent CD8 T cell responses against melanoma self-antigen tyrosinase-related protein 1 and generates antitumor immunity in mice. J Immunol (2009) 0.99

Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein. Mol Immunol (2000) 0.98

Lentivirus as a potent and mechanistically distinct vector for genetic immunization. Curr Opin Mol Ther (2007) 0.97

T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting. J Biol Chem (2012) 0.96

Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients. J Immunother (2013) 0.96

Challenges in cancer vaccine development for hepatocellular carcinoma. J Hepatol (2013) 0.95

Adoptive immunotherapy in postoperative hepatocellular carcinoma: a systemic review. PLoS One (2012) 0.95

Glypican-3 antibodies: a new therapeutic target for liver cancer. FEBS Lett (2013) 0.95

Lentivector expressing HBsAg and immunoglobulin Fc fusion antigen induces potent immune responses and results in seroconversion in HBsAg transgenic mice. Vaccine (2011) 0.92

Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma. Clin Chim Acta (2013) 0.88

AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in mice. J Hepatol (2010) 0.88

Alpha-fetoprotein (AFP)-derived peptides as epitopes for hepatoma immunotherapy: a commentary. Cancer Immunol Immunother (2008) 0.88

Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanoma. J Immunol (2011) 0.87

DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in mice. Cancer Gene Ther (2002) 0.86

Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes. Vaccine (2007) 0.85

Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice. Biochem Biophys Res Commun (2008) 0.85

Current status of therapy for hepatocellular carcinoma. Therap Adv Gastroenterol (2009) 0.84

Effective treatment of small murine hepatocellular carcinoma by dendritic cells. Hepatology (2001) 0.84

Alpha-fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer. Expert Opin Biol Ther (2008) 0.84

Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells. Liver Int (2006) 0.84

A DNA vaccine against chimeric AFP enhanced by HSP70 suppresses growth of hepatocellular carcinoma. Cancer Immunol Immunother (2006) 0.83

Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide. Int J Oncol (2013) 0.83

Immunotherapy of murine hepatocellular carcinoma by alpha-fetoprotein DNA vaccination combined with adenovirus-mediated chemokine and cytokine expression. Hum Gene Ther (2008) 0.82

Alpha fetoprotein is more than a hepatocellular cancer biomarker: from spontaneous immune response in cancer patients to the development of an AFP-based cancer vaccine. Curr Mol Med (2011) 0.82

Diverse efficacy of vaccination therapy using the alpha-fetoprotein gene against mouse hepatocellular carcinoma. Int J Mol Med (2004) 0.81

Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma. Hepatology (2014) 0.80

Targeting lentiviral vectors for cancer immunotherapy. Curr Cancer Ther Rev (2011) 0.80

Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm. J Viral Hepat (2007) 0.79

The immunogenicity of the tumor-associated antigen α-fetoprotein is enhanced by a fusion with a transmembrane domain. J Biomed Biotechnol (2012) 0.78

[Inhibitory effects of human AFP-derived peptide-pulsed dendritic cells on mouse hepatocellular carcinoma]. Ai Zheng (2008) 0.77

Specific cellular immunity and antitumor responses in C57BL/6 mice induced by DNA vaccine encoding murine AFP. Hepatobiliary Pancreat Dis Int (2004) 0.76

[Immunization with dendritic cells infected with human AFP adenovirus vector effectively elicits immunity against mouse hepatocellular carcinomas]. Zhonghua Zhong Liu Za Zhi (2006) 0.76

Articles by these authors

Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res (2009) 2.54

Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology (2005) 1.67

Role for Kruppel-like factor 4 in determining the outcome of p53 response to DNA damage. Cancer Res (2009) 1.16

Blockade of programmed death-1 pathway rescues the effector function of tumor-infiltrating T cells and enhances the antitumor efficacy of lentivector immunization. J Immunol (2010) 1.15

Effects of sleep and sleep deprivation on immunoglobulins and complement in humans. Brain Behav Immun (2006) 1.04

Medium optimization for the production of cyclic adenosine 3',5'-monophosphate by Microbacterium sp. no. 205 using response surface methodology. Bioresour Technol (2008) 0.94

Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism. Am J Physiol Heart Circ Physiol (2011) 0.94

Resveratrol attenuates early brain injury after subarachnoid hemorrhage through inhibition of NF-κB-dependent inflammatory/MMP-9 pathway. CNS Neurosci Ther (2013) 0.91

Reelin gene variants and risk of autism spectrum disorders: an integrated meta-analysis. Am J Med Genet B Neuropsychiatr Genet (2014) 0.90

Local administration of TLR ligands rescues the function of tumor-infiltrating CD8 T cells and enhances the antitumor effect of lentivector immunization. J Immunol (2013) 0.89

Serum glucose- and C-reactive protein-based assessment of stress status in a healthy population. Clin Lab (2010) 0.88

Anophthalmia: an uncommon manifestation of neurofibromatosis type 1. J Craniofac Surg (2011) 0.88

Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanoma. J Immunol (2011) 0.87

Genome-wide association study reveals constant and specific loci for hematological traits at three time stages in a White Duroc × Erhualian F2 resource population. PLoS One (2013) 0.86

[The study on heterogeneity of hepatitis B virus DNA]. Zhonghua Yi Xue Za Zhi (2002) 0.85

Renalase gene polymorphism in patients with hypertension and concomitant coronary heart disease. Kidney Blood Press Res (2014) 0.85

NS5ATP9, a gene up-regulated by HCV NS5A protein. Cancer Lett (2008) 0.84

Genome-wide association studies for hematological traits in Chinese Sutai pigs. BMC Genet (2014) 0.83

NS5ATP9 gene regulated by NF-kappaB signal pathway. Arch Biochem Biophys (2008) 0.82

Interaction between hepatitis C virus core protein and translin protein--a possible molecular mechanism for hepatocellular carcinoma and lymphoma caused by hepatitis C virus. World J Gastroenterol (2003) 0.81

Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection. Asian Pac J Cancer Prev (2015) 0.81

Quasispecies groups in the core promoter region of hepatitis B virus. Hepatobiliary Pancreat Dis Int (2002) 0.81

[A preliminary study on the heterogeneity of preS2 region in hepatitis B virus]. Zhonghua Nei Ke Za Zhi (2002) 0.80

Cloning and identification of NS5ATP2 gene and its spliced variant transactivated by hepatitis C virus non-structural protein 5A. World J Gastroenterol (2004) 0.80

Valproic acid: a new candidate of therapeutic application for the acute central nervous system injuries. Neurochem Res (2014) 0.80

Rapid degeneration of rod photoreceptors expressing self-association-deficient arrestin-1 mutant. Cell Signal (2013) 0.80

Role of rhodopsin and arrestin phosphorylation in retinal degeneration of Drosophila. J Neurosci (2012) 0.79

Comparison between routine and improved decompressive craniectomy on patients with malignant cerebral artery infarction without traumatic brain injury. J Craniofac Surg (2013) 0.79

Stir-baked Fructus gardeniae (L.) extracts inhibit matrix metalloproteinases and alter cell morphology. J Ethnopharmacol (2008) 0.78

Regulatory T cell in stroke: a new paradigm for immune regulation. Clin Dev Immunol (2013) 0.78

Screening of augmenter of liver regeneration-binding proteins by yeast-two hybrid technique. Hepatobiliary Pancreat Dis Int (2003) 0.78

[Advances in research on neuroprotective effects of inert gas]. Zhejiang Da Xue Xue Bao Yi Xue Ban (2011) 0.78

Application of closed irrigation-suction for postoperative infection control in plastic surgery. Plast Reconstr Surg (2010) 0.78

Maternal serum transformed alpha-fetoprotein levels in women with intrauterine growth retardation. Fetal Diagn Ther (2007) 0.78

Mirror-image arachnoid cysts in a pair of monozygotic twins: a case report and review of the literature. Int J Med Sci (2011) 0.78

L-type calcium current (ICa,L) and inward rectifier potassium current (IK1) are involved in QT prolongation induced by arsenic trioxide in rat. Cell Physiol Biochem (2011) 0.77

Propranolol regulates cardiac transient outward potassium channel in rat myocardium via cAMP/PKA after short-term but not after long-term ischemia. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.77

Three-dimensional quick response code based on inkjet printing of upconversion fluorescent nanoparticles for drug anti-counterfeiting. Nanoscale (2016) 0.76

Cloning and expression of the gene of augmenter of liver regeneration in yeast cells. Hepatobiliary Pancreat Dis Int (2002) 0.76

[Screening and cloning genes transactivated by TGF beta 1 in hepatic stellate cells using suppression subtractive hybridization technique]. Zhonghua Gan Zang Bing Za Zhi (2008) 0.76

Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein. Anticancer Res (2003) 0.76

Therapeutic use of human alpha-fetoprotein in clinical patients: is a cancer risk involved? Int J Cancer (2011) 0.76

[Screening and cloning gene of hepatocyte protein interacting with hepatitis C virus core protein]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2002) 0.76

Screening and cloning for proteins transactivated by the PS1TP5 protein of hepatitis B virus: a suppression subtractive hybridization study. World J Gastroenterol (2007) 0.75

Inkjet printing of upconversion nanoparticles for anti-counterfeit applications. Nanoscale (2015) 0.75

Mechanism of Cancer Growth Suppression of Alpha-Fetoprotein Derived Growth Inhibitory Peptides (GIP): Comparison of GIP-34 versus GIP-8 (AFPep). Updates and Prospects. Cancers (Basel) (2011) 0.75

Antitumor drug delivery modulated by a polymeric micelle with an upper critical solution temperature. Angew Chem Int Ed Engl (2015) 0.75

[Protein expression and function of gene 2 transregulated by hepatitis B virus pre-s1 protein and its cloning]. Zhonghua Gan Zang Bing Za Zhi (2008) 0.75

Chirality sensing using Ag⁺-thiol coordination polymers. Chem Commun (Camb) (2015) 0.75

Corrigendum: Antitumor Drug Delivery Modulated by A Polymeric Micelle Having Upper Critical Solution Temperature. Angew Chem Int Ed Engl (2015) 0.75

[Bilateral diffusive benign fibrous histiocytoma in retrobulbar muscle cone: a case report]. Zhejiang Da Xue Xue Bao Yi Xue Ban (2010) 0.75

[Identification and evaluation promoter sequence and the transcription activation of Hcbp6 interaction with core protein of hepatitis C virus]. Zhonghua Gan Zang Bing Za Zhi (2006) 0.75

Comparison of carotid artery endarterectomy and carotid artery stenting in patients with atherosclerotic carotid stenosis. J Craniofac Surg (2014) 0.75

[Clinical application of a new titanium clip applier in transsphenoidal surgery]. Zhonghua Yi Xue Za Zhi (2013) 0.75

[Function of TTG1A in hepatic stellate cells]. Zhonghua Gan Zang Bing Za Zhi (2009) 0.75

Brain ischemia induces regeneration of interneurons but not projection neurons. Restor Neurol Neurosci (2013) 0.75

[HBV transinfected enhances the PD-L expression of cytokines stimulating]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2008) 0.75

[Screening up-regulated genes in hepatic stellate cells treated with PDGF-BB using suppression subtractive hybridization technique]. Zhonghua Gan Zang Bing Za Zhi (2007) 0.75

Effect of short hairpin RNA of Bcl-xL gene on biological behaviors of HepG-2 cells. Med Oncol (2011) 0.75

Enhanced uridine diphosphate N-acetylglucosamine production using whole-cell catalysis. Appl Microbiol Biotechnol (2009) 0.75

[Mercury pollution investigation in predominant plants surrounding Shenzhen Qingshuihe municipal solid waste incineration plant]. Huan Jing Ke Xue (2009) 0.75

[Mutual interaction between hepatitis C virus core protein and translin, a recombination hotspot binding protein]. Zhonghua Yi Xue Za Zhi (2002) 0.75

[A study on differentially expressed genes in hepatic stellate cells treated with transforming growth factor beta 1 using cDNA microarray technique]. Zhonghua Gan Zang Bing Za Zhi (2008) 0.75

Cancer during pregnancy: what is the role of maternal serum and placental biomarkers? A review and commentary. Tumori (2015) 0.75

[Expression, purification and enzymatic characterization of Thermus thermophilus HB8 aspartate aminotransferase in Escherichia coli]. Sheng Wu Gong Cheng Xue Bao (2007) 0.75

Screening of genes for proteins interacting with the PS1TP5 protein of hepatitis B virus: probing a human leukocyte cDNA library using the yeast two-hybrid system. Chin Med J (Engl) (2006) 0.75

[Screening and cloning of encoding genes of proteins interacting with retinol dehydrogenase 11 using yeast two-hybrid technique]. Zhonghua Gan Zang Bing Za Zhi (2008) 0.75

Efficacy of kidney-tonifying traditional Chinese medicine prescriptions in hypoplastic uterus treatment: a systematic review and meta-analysis. J Obstet Gynaecol Res (2014) 0.75

Epilepsy as the first presentation of arterial tortuosity syndrome in a young girl: a case report. Turk Neurosurg (2014) 0.75

[Effect of bicyclol on gene expression profiles in mice with liver injury induced by concanavalin A]. Yao Xue Xue Bao (2008) 0.75